In this episode, HemoAware founder, Jesse John Francis Clark, discusses the recent drama at this local Hemophilia Treatment Center.

The show to promote public awareness about rare inherited bleeding disorders. Jesse John Francis Clark is a serial entrepreneur that was bor

Over the weekend, HemoAware uploaded a video of founder, Jesse John Francis Clark, reviewing Sanofi's Phase 3 clinical trial for BIVV001.

The National Hemophilia Foundation (NHF) has received a $500,000 grant from the Centers for Disease Control and Prevention (CDC) to support

John Francis Clark, Founder of HemoAware, launches biotechnology company to develop a cure for Hemophilia and other inherited bleeding disor

We had a good laugh when we saw this ad on Hemophilia of Georgia's social media.

Today was a big blow for BioMarin and its gene therapy product, valoctocogene roxaparvovec for severe hemophilia A BioMarin announced tha...

For the first time since 1948, the National Hemophilia Foundation finally realizes that they need a diverse board. For the past 72 years,...

We have been infored that BioMarin has named it's gene therapy prodict. It was named Valrox but the new commercial name is Roctavian. We ...

All information below was researched and written by Jesse John Francis Clark. This is Dr. Robert Sidonio, Jr currently hailing out of Chi...